Abstract
Preliminary study of novel SRC tyrosine kinase inhibitor and proton therapy combined effect on glioblastoma multiforme cell line: In vitro evaluation of target therapy for the enhancement of protons effectiveness
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have